All Access Articles |
- Cullinan Therapeutics Begins NDA Process for Zipalertinib Combination Therapy | 2026-10-02 | UNITED STATES
- Cullinan Therapeutics Set to Unveil Three Pipeline Updates in Q4 2026 | 2026-09-24 | BIOTECHNOLOGY
- Cullinan Therapeutics Reports Positive Phase 3 Results | 2026-09-14 | BIOTECHNOLOGY
- Cullinan Therapeutics Reports Promising Clinical Data | 2026-06-10 | BIOTECHNOLOGY